News

September 29, 2023

Laverock raises £13.5m to commercialise gene editing induced gene silencing platform (GEiGS®)

September 25, 2023

Congratulations Ishani Malhotra from Carcinotech for being a finalist in the EY Entrepreneur of the Year

September 15, 2023

Dewpoint Therapeutics Partners with Chemify to apply ground-breaking Chemistry AI to radically accelerate the discovery of molecules

August 22, 2023

Eos portfolio company ENOUGH raises 40m euro scale-up equity investment

August 2, 2023

Glasgow firm Chemify raises £33m to ‘digitise’ chemistry

July 17, 2023

Carcinotech – How Bioprinting Can Improve Cancer Treatments

All News

Laverock raises £13.5m to commercialise gene editing induced gene silencing platform (GEiGS®)

September 29, 2023

Congratulations Ishani Malhotra from Carcinotech for being a finalist in the EY Entrepreneur of the Year

September 25, 2023

Dewpoint Therapeutics Partners with Chemify to apply ground-breaking Chemistry AI to radically accelerate the discovery of molecules

September 15, 2023

Eos portfolio company ENOUGH raises 40m euro scale-up equity investment

August 22, 2023

Glasgow firm Chemify raises £33m to 'digitise' chemistry

August 2, 2023

Carcinotech - How Bioprinting Can Improve Cancer Treatments

July 17, 2023

CNBC report about how ENOUGH, the Strathclyde spin-out and Eos portfolio company, thinks its fungi-based protein may be the solution to the unsustainable impact of sole reliance on traditional protein farming

July 6, 2023

British Business Investments commits £10m via its Regional Angels Programme

June 20, 2023

A warm welcome to Jill Arnold CA to the Eos team. As we continue to support impactful science and technology across Scotland and beyond, we really value the experience and vision that Jill brings to our work

April 27, 2023

Welcoming Bioliberty to the Eos portfolio

April 4, 2023

Stewart demands government action on female entrepreneurship

March 8, 2023

Significant growth round for Dxcover’s early stage cancer test

February 1, 2023

Discover

Contact

Eos Advisory LLP,
Kinburn Castle,
Doubledykes Road,
St Andrews, KY16 9DR

Eos Advisory LLP is a Limited Liability Partnership registered in Scotland with registered number SO306577. Registered Office: Kinburn Castle, Doubledykes Road, St Andrews, KY16 9DR. Eos Advisory LLP is authorised and regulated by the Financial Conduct Authority (FCA), reference number 980583.

News

September 29, 2023

Laverock raises £13.5m to commercialise gene editing induced gene silencing platform (GEiGS®)

September 25, 2023

Congratulations Ishani Malhotra from Carcinotech for being a finalist in the EY Entrepreneur of the Year

September 15, 2023

Dewpoint Therapeutics Partners with Chemify to apply ground-breaking Chemistry AI to radically accelerate the discovery of molecules

August 22, 2023

Eos portfolio company ENOUGH raises 40m euro scale-up equity investment

August 2, 2023

Glasgow firm Chemify raises £33m to ‘digitise’ chemistry

July 17, 2023

Carcinotech – How Bioprinting Can Improve Cancer Treatments

All News

September 29, 2023

Read more

September 25, 2023

Read more

September 15, 2023

Read more

August 22, 2023

Read more

August 2, 2023

Read more

July 17, 2023

Read more

July 6, 2023

Read more

June 20, 2023

Read more

April 27, 2023

Read more

April 4, 2023

Read more

March 8, 2023

Read more

February 1, 2023

Read more

Discover

Links

Contact

© Eos Advisory LLP,

2023

| All rights reserved

Latest news

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.